Tectonic Therapeutic, Inc. TECX

Rank #1727 · Nasdaq · $0.4B market cap

⚠ Going-concern flag — the auditor (Deloitte & Touche LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

43.5

P/E

-6.4

P/B

-4.41

ROE

68.5%

Op. Margin

–%

Debt Ratio

-14%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -6.4x, P/B -4.41x. Ranks in the top 94% of the universe.

Profitability ★★★★★

Excellent

ROE 68.5%. Ranks in the top 6% of the universe.

Safety ★★★★★

Excellent

Debt ratio -14%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2018	–	$-0.0B	$-0.0B	$-0.0B	–	-80
2019	–	$-0.0B	$-0.0B	$-0.0B	–	-49
2020	–	$-0.1B	$-0.1B	$0.1B	–	12
2021	–	$-0.1B	$-0.1B	$0.2B	–	9
2022	–	$-0.1B	$-0.1B	$0.3B	–	14
2023	–	$-0.1B	$-0.1B	$0.2B	–	17
2024	–	$-0.0B	$-0.0B	$-0.0B	–	-95
2025	–	$-0.1B	$-0.1B	$-0.1B	–	-14

← See the full screener